Kessler, Tobias
Ito, Jakob
Wick, Wolfgang
Wick, Antje
Funding for this research was provided by:
Ruprecht-Karls-Universität Heidelberg
Article History
Received: 14 October 2022
Accepted: 13 December 2022
First Online: 25 December 2022
Declarations
:
: Wolfgang Wick is one of the inventors and patent-holders on ‘Peptides for use in treating or diagnosing IDH1R132H positive cancers’ (EP2800580B1). All other authors have no relevant financial or non-financial interests to disclose.